Age Related Multiple Sclerosis Severity Score: Disability ranked by age

Author:

Manouchehrinia Ali1,Westerlind Helga2,Kingwell Elaine3,Zhu Feng3,Carruthers Robert3,Ramanujam Ryan1,Ban Maria4,Glaser Anna1,Sawcer Stephen4,Tremlett Helen3,Hillert Jan1

Affiliation:

1. Department of Clinical Neuroscience (CNS), Karolinska Institutet, Stockholm, Sweden

2. Institute of Environmental Medicine (IMM), Karolinska Institutet, Stockholm, Sweden

3. Division of Neurology, Faculty of Medicine, UBC Hospital, The University of British Columbia, Vancouver, BC, Canada

4. Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK

Abstract

Background: The Multiple Sclerosis Severity Score (MSSS) is obtained by normalising the Expanded Disability Status Scale (EDSS) score for disease duration and has been a valuable tool in cross-sectional studies. Objective: To assess whether use of age rather than the inherently ambiguous disease duration was a feasible approach. Method: We pooled disability data from three population-based cohorts and developed an Age Related Multiple Sclerosis Severity (ARMSS) score by ranking EDSS scores based on the patient’s age at the time of assessment. We established the power to detect a difference between groups afforded by the ARMSS score and assessed its relative consistency over time. Results: The study population included 26058 patients from Sweden ( n = 11846), Canada ( n = 6179) and the United Kingdom ( n = 8033). There was a moderate correlation between EDSS and disease duration ( r = 0.46, 95% confidence interval (CI): 0.45–0.47) and between EDSS and age ( r = 0.44, 95% CI: 0.43–0.45). The ARMSS scores showed comparable power to detect disability differences between groups to the updated and original MSSS. Conclusion: Since age is typically unbiased and readily obtained, and the ARMSS and MSSS were comparable, the ARMSS may provide a more versatile tool and could minimise study biases and loss of statistical power caused by inaccurate or missing onset dates.

Funder

Cambridge NIHR Biomedical Research Centre

Neuroförbundet

Biogen

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3